These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 33447033)

  • 1. Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines.
    Albalawi F; Hussein MZ; Fakurazi S; Masarudin MJ
    Int J Nanomedicine; 2021; 16():161-184. PubMed ID: 33447033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.
    Liu Q; Wang X; Xia T
    Anal Bioanal Chem; 2018 Sep; 410(24):6097-6111. PubMed ID: 30066194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
    Nguyen NHA; Falagan-Lotsch P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Literature Review of (Q)SAR Modelling of Nanomaterial Toxicity.
    Oksel C; Ma CY; Liu JJ; Wilkins T; Wang XZ
    Adv Exp Med Biol; 2017; 947():103-142. PubMed ID: 28168667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine applications in orthopedic medicine: state of the art.
    Mazaheri M; Eslahi N; Ordikhani F; Tamjid E; Simchi A
    Int J Nanomedicine; 2015; 10():6039-53. PubMed ID: 26451110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology in soil remediation - applications vs. implications.
    Qian Y; Qin C; Chen M; Lin S
    Ecotoxicol Environ Saf; 2020 Sep; 201():110815. PubMed ID: 32559688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery.
    Palombo M; Deshmukh M; Myers D; Gao J; Szekely Z; Sinko PJ
    Annu Rev Pharmacol Toxicol; 2014; 54():581-98. PubMed ID: 24160695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting nanomaterials pulmonary toxicity in animals by cell culture models: Achievements and perspectives.
    Di Ianni E; Jacobsen NR; Vogel U; Møller P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1794. PubMed ID: 36416018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms, Characterization Methods, and Utilities of Nanoparticle Biotransformation in Nanosafety Assessments.
    Cai X; Liu X; Jiang J; Gao M; Wang W; Zheng H; Xu S; Li R
    Small; 2020 Sep; 16(36):e1907663. PubMed ID: 32406193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the development of nanoparticle-based imaging agents: Characterization and biology.
    Crist RM; Dasa SSK; Liu CH; Clogston JD; Dobrovolskaia MA; Stern ST
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1665. PubMed ID: 32830448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin contamination of engineered nanomaterials: Overcoming the hurdles associated with endotoxin testing.
    Hannon G; Prina-Mello A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1738. PubMed ID: 34254460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At the Crossroads of Nanotoxicology in vitro: Past Achievements and Current Challenges.
    Hussain SM; Warheit DB; Ng SP; Comfort KK; Grabinski CM; Braydich-Stolle LK
    Toxicol Sci; 2015 Sep; 147(1):5-16. PubMed ID: 26310852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
    Westmeier D; Stauber RH; Docter D
    Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory.
    Caputo F; Mehn D; Clogston JD; Rösslein M; Prina-Mello A; Borgos SE; Gioria S; Calzolai L
    J Chromatogr A; 2021 Jan; 1635():461767. PubMed ID: 33310281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brave new world revisited: Focus on nanomedicine.
    Fadeel B; Alexiou C
    Biochem Biophys Res Commun; 2020 Nov; 533(1):36-49. PubMed ID: 32921412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity mechanism of engineered nanomaterials: Focus on mitochondria.
    Yao Y; Zhang T; Tang M
    Environ Pollut; 2024 Feb; 343():123231. PubMed ID: 38154775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review.
    Feng X; Shi Y; Zhang Y; Lei F; Ren R; Tang X
    Int J Nanomedicine; 2024; 19():1509-1538. PubMed ID: 38384321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Nanotoxicology and Nanomedicine: A special issue of the Food and Chemical Toxicology.
    Sahu SC
    Food Chem Toxicol; 2015 Nov; 85():1. PubMed ID: 26248127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.